Abiopharma

CLEARPOINT NEURO, INC. (CLPT)

Symbol	CLPT
Name	CLEARPOINT NEURO, INC.
Sector	HEALTH CARE
Region	North America
Industry	Surgical & Medical Instruments & Apparatus
Address	120 S. SIERRA AVENUE, SOLANA BEACH, CA 92075
Telephone	9499006833
Fax	—
Email	—
Website	https://www.clearpointneuro.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001285550
Description	ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Companys flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide. Additional info from NASDAQ: ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Companys flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.

2026-04-29 20:10

ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026

2026-04-23 18:21

New Form ARS - ClearPoint Neuro, Inc. Filed: 2026-04-23 AccNo: 0001193125-26-174046 Size: 557 KB

2026-04-23 18:08

New Form DEFA14A - ClearPoint Neuro, Inc. Filed: 2026-04-23 AccNo: 0001193125-26-173988 Size: 529 KB

2026-04-22 20:05

ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-04-20 20:05

ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint

2026-04-20 17:18

New Form SCHEDULE 13G/A - ClearPoint Neuro, Inc. Filed: 2026-04-20 AccNo: 0000921895-26-001034 Size: 20 KB

2026-04-10 17:31

New Form DEF 14A - ClearPoint Neuro, Inc. Filed: 2026-04-10 AccNo: 0001193125-26-151345 Size: 4 MB

2026-04-02 18:53

FLETCHER R JOHN 🟢 acquired 1.3K shares of ClearPoint Neuro, Inc. (CLPT) at $9.10 Transaction Date: Apr 01, 2026 | Filing ID: 139797

2026-04-02 18:52

Girin Pascal E R 🟢 acquired 755 shares of ClearPoint Neuro, Inc. (CLPT) at $9.10 Transaction Date: Apr 01, 2026 | Filing ID: 139783

2026-04-02 18:49

Richards Timothy T. 🟢 acquired 442 shares of ClearPoint Neuro, Inc. (CLPT) at $9.10 Transaction Date: Apr 01, 2026 | Filing ID: 139777

No clinical trials found for this company.

No clinical products found for this company.